CSMD1 and cancer: Aberrant splicing in CSMD1 has been associated with cancer susceptibility [42], while some studies report association between CSMD1 mutations and phenotypic variance in neuropsychological disorders [37–39], but it has no documented effect on any ocular phenotype.